Literature DB >> 16236039

Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin.

Hitoshi Ando1, Shuichi Tsuruoka, Hayato Yanagihara, Koh-ichi Sugimoto, Masaaki Miyata, Yasushi Yamazoe, Toshinari Takamura, Shuichi Kaneko, Akio Fujimura.   

Abstract

AIMS: To compare the effects of grapefruit juice (GFJ) on the pharmacokinetics of pitavastatin and atorvastatin.
METHODS: In a randomized, four-phase crossover study, eight healthy subjects consumed either GFJ or water t.i.d. for 4 days in each trial. On each final day, a single dose of 4 mg pitavastatin or 20 mg atorvastatin was administered.
RESULTS: GFJ increased the mean AUC(0-24) of atorvastatin acid by 83% (95% CI 23-144%) and that of pitavastatin acid by 13% (-3 to 29%).
CONCLUSIONS: Pitavastatin, unlike atorvastatin, appears to be scarcely affected by the CYP3A4-mediated metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236039      PMCID: PMC1884940          DOI: 10.1111/j.1365-2125.2005.02462.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.

Authors:  L Q Guo; K Fukuda; T Ohta; Y Yamazoe
Journal:  Drug Metab Dispos       Date:  2000-07       Impact factor: 3.922

Review 2.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management.

Authors:  Kouji Kajinami; Noboru Takekoshi; Margaret E Brousseau; Ernst J Schaefer
Journal:  Atherosclerosis       Date:  2004-12       Impact factor: 5.162

4.  Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.

Authors:  J J Lilja; K T Kivistö; P J Neuvonen
Journal:  Clin Pharmacol Ther       Date:  1999-08       Impact factor: 6.875

Review 5.  Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor.

Authors:  Kouji Kajinami; Noboru Takekoshi; Yasushi Saito
Journal:  Cardiovasc Drug Rev       Date:  2003

6.  Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization.

Authors:  H Fujino; I Yamada; S Shimada; M Yoneda; J Kojima
Journal:  Xenobiotica       Date:  2003-01       Impact factor: 1.908

7.  Effects of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese.

Authors:  Ichiro Fukazawa; Naoki Uchida; Eiji Uchida; Hajime Yasuhara
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

  7 in total
  22 in total

1.  Elucidating the role of dose in the biopharmaceutics classification of drugs: the concepts of critical dose, effective in vivo solubility, and dose-dependent BCS.

Authors:  Georgia Charkoftaki; Aristides Dokoumetzidis; Georgia Valsami; Panos Macheras
Journal:  Pharm Res       Date:  2012-07-04       Impact factor: 4.200

Review 2.  Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

Authors:  David G Bailey
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

Review 3.  Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Authors:  David G Bailey; George Dresser; J Malcolm O Arnold
Journal:  CMAJ       Date:  2012-11-26       Impact factor: 8.262

4.  ABT-737 and pictilisib synergistically enhance pitavastatin-induced apoptosis in ovarian cancer cells.

Authors:  Elizabeth De Wolf; Christopher De Wolf; Alan Richardson
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

Review 5.  The effect of grapefruit juice on drug disposition.

Authors:  Michael J Hanley; Paul Cancalon; Wilbur W Widmer; David J Greenblatt
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01-22       Impact factor: 4.481

Review 6.  Grapefruit-drug interactions.

Authors:  Kay Seden; Laura Dickinson; Saye Khoo; David Back
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

Review 7.  Pitavastatin: a review of its use in the management of hypercholesterolaemia or mixed dyslipidaemia.

Authors:  Sean T Duggan
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

Review 8.  Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals.

Authors:  Yasushi Saito
Journal:  Vasc Health Risk Manag       Date:  2009-11-16

Review 9.  Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

10.  Almorexant effects on CYP3A4 activity studied by its simultaneous and time-separated administration with simvastatin and atorvastatin.

Authors:  Matthias Hoch; Petra Hoever; Rudolf Theodor; Jasper Dingemanse
Journal:  Eur J Clin Pharmacol       Date:  2013-01-20       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.